Axa
MJN

Axa’s Mead Johnson Nutrition Company MJN Stock Holding History

Axa’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-254,683
Closed -$22.7M – 1348
2017
Q1 		$22.7M Sell
254,683
-107,742
-30% -$8.86M 0.1% 248
2016
Q4 		$25.6M Buy
362,425
+205
+0.1% +$15.3K 0.12% 212
2016
Q3 		$28.6M Buy
362,220
+1,124
+0.3% +$95.9K 0.13% 210
2016
Q2 		$32.8M Sell
361,096
-1,555
-0.4% -$132K 0.15% 188
2016
Q1 		$30.8M Sell
362,651
-8,934
-2% -$665K 0.14% 193
2015
Q4 		$29.3M Buy
371,585
+73,424
+25% +$5.78M 0.13% 213
2015
Q3 		$21M Sell
298,161
-30,384
-9% -$2.5M 0.09% 241
2015
Q2 		$29.6M Buy
328,545
+23,519
+8% +$2.27M 0.12% 201
2015
Q1 		$30.7M Buy
305,026
+2,915
+1% +$294K 0.13% 196
2014
Q4 		$30.4M Buy
302,111
+3,791
+1% +$378K 0.12% 199
2014
Q3 		$28.7M Sell
298,320
-4,324
-1% -$410K 0.12% 209
2014
Q2 		$28.2M Buy
302,644
+7,777
+3% +$680K 0.12% 205
2014
Q1 		$24.5M Sell
294,867
-7,115
-2% -$577K 0.11% 218
2013
Q4 		$25.3M Buy
301,982
+23,162
+8% +$1.89M 0.11% 210
2013
Q3 		$20.7M Sell
278,820
-1,532
-0.5% -$115K 0.1% 228
2013
Q2 		$22.2M Buy
+280,352
New +$22.5M 0.12% 196

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Axa's MJN Position: Q2 2017 in Review

Axa sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 254,683 shares — an estimated $22.7M sold.

Axa first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $32.8M in Q2 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Axa reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Axa sold 254,683 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $22.7M.
  • Axa first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Axa's Mead Johnson Nutrition Company position peaked at $32.8M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.